Principles and Practice of Nuclear Medicine and Correlation Medical Imaging RD Lele
INDEX
A
14C-glycochoic acid 350
Acute appendicitis 348
Adaline and delta rule 128
applications of ANN in image
interpretation 129
future of ANNs 132
Kohonen mapping 131
use of ANN for PET/SPECT
images 131
Adipocytokines 237
Adrenal glands 196
adrenal cortex 196
anatomy 196
glucocotricoid disorders 197
glucocorticoid excess 197
glucocotricoid deficiency 198
imaging of pituitary and adrenals 196
mineralocorticoid disorders 198
mineralocorticoid excess 198
stress response and immune-
endocrine axis 196
Alcoholic liver disease 366
Alimentary tract 338
acute GI bleeding 347
bicompartmental gastric
emptying 344
colonic transit 345
gastric acid secretion 344
estimation of gastric acid
secretion 344
gastric emptying 343
gastroesophageal reflux 343
gastrointestinal blood loss 347
gastrointestinal protein loss 345
gastrointestinal scintigraphy 338
locating the site of GI bleeding 347
pulmonary aspiration 341
radionuclide esophageal transit
scintigraphy 341
salivary glands scintigraphy 341
small bowel and colonic transit 345
tests of intestinal absorption 339
calcium 339
fats 339
iron 340
phosphorus 340
sugars 339
vitamin B12 340
Altered gene expression in fetus 302
Anterior pituitary 192
gluscose3 suppression test for
acromegaly 192
growth hormone 192
HCG human chorionic
gonadotrophin 195
HPL human placental lactogen
LH luteinizing hormone 193
hormone excess in males 194
male gonadal function 193
progesterone 195
prolactin (PRL) 193
Antioxidized LDL antibodies 236
Antiplatelet antibodies 333
B
Bile acid malabsorption 350
Biliary atresia vs neonatal hepatitis
Biliary obstruction and cholecystitis
in children 370
Bone marrow regeneration 390
Bone scanning for tumor metastases
Bone tuberculosis 409
Bowman's space 275
Brain as a target of gonadal hormones
Brain death determination 163
Brain scanning for blood brain barrier
abnormal dynamic—abnormal
static 137
abnormal dynamic—normal
static 136
normal static scan 137
CSF rhinorrhea 151
evaluation of shunt patency 151
interpretation of results 150
normal dynamic¾abnormal static
normal dynamic¾normal static
C
C peptide deficiency and endothelial
dysfunction 238
EDHF 239
hyperhomocysteinemia 239
improving endothelial function 241
ACE-inhibitors and
angiotensin receptor
blockers 242
advanced glycosylation end
products 242
erythropoietin 242
exercise training 242
lipid lowering agents 242
nifedipine and lacidipine 242
nitrates (glyceryl trinitrate
isosorbide dinitrate 242
tetrahydrobiopterin (BH4)
ischemia induced by mental
stress 239
methods 243
results 243
silent ischemia and silent
myocardial infarction 241
women and CAD 239
Captopril renogram 295
Captopril renography 299
Cardiac regenerative therapy 270
Cardiac spiral CT 106
Causes of anemia 387
Cell population dynamics 73
Cell population dynamics of cancer
Central nervous system disease 135
Central role of renal handling of salt
Cerebral perfusion imaging in HIV/
AIDS 158
Chronic obstructive pulmonary
disease 328
Computer for MRI 110
Computer-assisted medical imaging
artifacts in ultrasonography 98
computed X-ray tomography 100
contrast agents for US 98
CT scanners in four generations 101
first generation system 101
fourth generation system 101
second generation system 101
third generation system 101
data acquisition system 101
Doppler ultrasonography 96
imaging principles in CT 100
intraoperative ultrasonography 99
intravascular ultrasound (IVUS) 97
laparoscopic sonography 100
operator dependence 97
pulsed wave Doppler 96
tissue characterization 97
transesophageal
echocardiography 95
ultrasound imaging:
ultrasonography 92
ultrasound instrumentation 93
acousting impedence 94
A-mode 95
annular arrays 94
B-mode (brightness mode) 95
curved arrays 94
linear array 93
M-mode (motion mode) 95
phased array 94
ultrasound-guided interventions 98
Computer-derived renogram 280
Conn's syndrome 198
adrenal androgenic disorders 199
adrenal imaging 199
limitations of adrenal
scintigraphy 199
adrenal medulla 200
mineralocortcoid deficiency 199
parathyroid hormone 200
scintigraphic diagnosis of
hyperplasia and adenoma 203
Consciousness 171
challenges with phenotyping 172
chronic fatigue syndrome 175
autistic disorders 175
effect of hypnosis 175
fundamental conceptual issues
genetic considerations in
psychiatric disorders 172
molecular imaging, genetics and
pharmacology 176
neuroimaging of mental
disorders 172
objective study of hallucinations
obsessive compulsive disease 175
resting state networks (RSNs) in
the brain 178
study of silent ischemic with PET
Coronary collateral circulation and
microcirculation 263
Crohn's disease 436
CT venography 334
D
Detection of bacterial deconjugation
of bile salts 351
Diffusion tractography 113
magnetoencephalography (MEG)
MR spectroscopy 114
virtual endoscopy 115
Discordance between Sc and
mebrofenin images 370
Discovery of new hormone receptors:
vitamin D receptors 75
axonal transport 77
mapping cerebral metabolism 77
mapping functional architecture
Diuretic renography 284
DMSA 293
Doppler ultrasonography 334
Dual source cyclotron 12
E
Echoplannar imaging 111
Electron beam CT 102
Endocannabinoid (EC) system
activation 237
Endothelial dysfunction 232
causation 232
demonstration of endothelial
dysfunction 235
EPC dysfunction 235
normal endothelial function 233
prevention 232
reversal of vascular 232
Engelmann's syndrome 405
EPA and DHA 236
Estimation of GFR of individual
kidneys 283
Evaluation and management of
urolithiasis 284
Evaluation of renal transplants 287
Evidence of angiogenesis 271
Experimental study of depression in
small animal 86
HPA axis in depression 89
monoamine theory 88
neurotrophin hypothesis 88
F
Fat malabsorption 350
FDG uptake and myocardial viability
Fibrous dysplasia 413
adamantinoma 418
aneurismal bone cyst 414
bone islands 413
bone lymphoma 418
Ewing's tumor 417
fibrous histiocytoma 416
giant cell tumor 415
hemangioma 416
monostotic 413
osteoblastoma 414
osteochondroma 414
osteoid osteomas 413
osteosarcoma 416
Fluroinsonidazole 267
Foley catheter 293
Fourier transformation 109
G
Gastrin 352
Gastroenteropancreatic tumors 353
Gestalt interpretation 324
Gut-hormones 351
H
Hashimoto encephalopathy 217
Helical CT and CT pulmonary
angiography 323
Hepatic exretion half time 369
Hepatic extraction fraction 367
Hepatic fibrosis 370
Hepatobiliary imaging for gall
bladder disease 371
Caroli's disease 372
chronic acalculus biliary disease
hepatic trauma 372
radiotracers to study liver
metabolism 372
sphincter of Oddi (SOD)
dysfunction 372
Hepatobiliary scintigraphy 367
Hepatogram curve 368
Hippura renogram 279
Human endothelial progenitor cells
Humanized mice in translational
biomedical research 86
Hybrid SPECT/CT and PET/CT 263
Hypoxic ischemic encephalopathy
I
I-123 IMP brain SPECT in reflex
sympathetic dystrophy 159
I-131 labeled sodium di-
iodofluorescein 135
Image reconstruction algorithms 62
Imaging apoptosis in the liver 373
Imaging hepatic necrosis 374
Imaging hepatic transplant 375
Imaging inflammation and infection
antimicrobial peptides 436
Avidin-Biotin system 435
clinical problems 431
gallium-67 434
imaging specific infection 438
leukocyte labeling 435
non-specific immunoglobulin
radioimmunoscintigraphy of
tuberculosis 438
radiolabel antimicrobials 436
radiolabeled aptamers 441
radiolabeled cytokines 435
Imaging myocardial hypoxia 267
Imaging of bone tumors 411
bone cyst 411
chondromyxoid fibroma 412
fibroma 412
fibrous cortical defect 412
ossifying fibroma 412
Immunoradiometric assay (IRMA)
Indium generator 16
Instruments in nuclear medicine 41
accelerator mass
spectrometry(AMS) 43
breath analysis of C-14 CO2 with
LSC 43
computer in nuclear medicine 48
computerized emission
tomography 57
data acquisition 49
era of fusion imaging 60
instrumentation: in vivo imaging 45
collimators 45
positron camera:tomography
rectilinear scanners 46
scintillation camera 46
liquid scintillation counters 43
Michigan corridor 4DM 60
modes of dynamic data
acquisition 51
nuclear medicine computer
systems 48
quantification of SPECT MPS 60
remote reading with the
worldwide web 60
scintillation detectors 41
counting rate meters 42
software in nuclear medicine 50
acquisition programs 50
area of interest selection 51
display programs 50
dynamic flow curve
quantitation 51
transformations 50
spect/CT imaging 60
storage of data 52
color coding 54
data bounding 53
dual isotope subtraction
image 56
functional or parametric
images 55
smoothing 53
time activity curves 55
uniformity corrections 53
variable background
subtraction 53
variable contrast and
brightness 53
Insulin resistance 225
causes 227
evolution of the concept 226
molecular mechanisms 229
unique hormone 225
L
Lactose malabsorption 350
Lung imaging in cancer 330
Lymphedema 335
causes 335
clinical application of
lymphoscintigraphy 335
normal scintigraphic pattern
grades of obstruction 337
pathophysiology 335
Lymphoscintigraphy 334
M
Mapping selective neuronal loss 163
Mechanism of action of hormones 75
Meckel's diverticulum 348
Mitral stenosis 331
Molecular imaging in dementia 160
Morphological information 292
Mouse models of human disease 85
MR venography 334
Multinodular goiter 221
diagnosis 221
treatment 222
Myocardial amyloidosis 270
Myocardial apoptosis 269
Myocardial infarction 268
Myocardial innervation 269
Myocardial metabolism 266
Myocardial stem cells 271
Myocardial stunning and hibernation
Myxoedema coma 217
N
Neural crest tumor 353
Neurocomputers 126
basics of ANNs 128
historical development of ANNs 127
pattern recognition 126
sequential vs parallel processing 126
Neutron activation analysis 65
biomedical applications 66
clinical utility of neutron
activation analysis 69
delayed gamma NAA 68
five level model of body
composition 68
neutron reactions 65
prompt gamma NAA 68
resonant gamma activation 68
New role of HMPAO SPECT in
studies of congniton 179
Newer techniques in MRI 111
dynamic adaptive MRI 113
functional MRI 111
MR angiography 113
MR venography 113
phase contrast MRA 113
Nuclear cardiology 249
clinical application of myocardial
perfusion imaging 258
diastolic dysfunction 261
myocardial perfusion imaging
PET perfusion tracers 257
prognostic value of exercise MPS
radionuclide angiography 249
radionuclide ventriculography
sestamibi 257
tetrofosmin 257
Nuclear magnetic resonance (NMR)
Nuclear medicine 1
molecular biology and nuclear
medicine 1
nature of radiation energy 7
nuclear magnetic resonance 6
radioactive decay 8
scope of diagnostic nuclear
medicine procedures 2
structure of the atom 4
tracter principle 1
Nuclear medicine in oncology 443
antisense oligonucleotides 455
attributes of the cancer cell 443
bone scanning in lung cancer 456
bone scanning in multiple
myeloma 457
bone scanning in osteosarcoma
cancer stem cells 443
carcinoid tumors 452
clinical applications of radio-
immunodetection (RID) 454
clinical PET in oncology 457
comparison between Ga-67 and
FDG PET 447
comparison between TI-201 and
Tc-sestamibi 449
gallium scintigraphy for cancer
medullary thyroid carcinoma
(MCT) 452
MIBG for imaging
neuroendocrine tumors 449
neuroblastoma (NB) 451
peptide receptor scintigraphy in
oncology 452
scanning for skeletal metastases
tumor-seeking radiopharma-
ceuticals 445
use of tumor-specific labeled
antibodies 453
Nuclear medicine in orthopedics 292
bone scanning in fractures 394
bone scanning in metabolic bone disease 401
procedure of bone scanning 394
radionuclides used to study bone 393
early tracers used 393
technetiunm 99m phosphate
compounds 393
study of septic necrosis 398
O
Obstructive uropathy 283
P
Paget's disease 409
Parkinson's disease 158
Patterns of joint scans 427
Pediatric nuclear medicine 8
PET and SPECT in Huntington's
disease 158
PET imaging in brain tumors 155
PET in lymphoma 459
PET-FDG for glucose metabolism
Pleiotropic glycoprotein expression
Pleural effusion in cirrhosis 366
Portal hypertension 371
Positron tomography 157
Positron-emitting radionuclides 13
Possibility of cardiac regeneration
Principles of NMR imaging and
spectroscopy 107
Procalcitonin 295
Protein synthesis 74
Pulmonary embolism mimics 326
clinical approach 326
Pulmonary tuberculosis 329
Pyelonephritis imaging 295
R
Radiation effects 481
classification 483
Radioimmuno-guided surgery
(RIGS) 477
Radioisotope techniques in
endocrinology and metabolism
autoradiography 183
inverted intestinal loop 183
labeled embryonic rate bone
biosynthesis of hormones 184
assay of hormones 184
peptide hormones 184
rate of production of
hormones 184
steroid hormones 184
competitive binding to transins 187
histology 181
dilution principle 182
paper chroma to graphy 183
radioisotope techniques 182
radio-labeled compounds 182
problems and pitfalls in RIA 186
circulating fragments 187
cross reactivity between
different hormones 187
normal secretion of more than
one form of hormone 187
precursors of peptide
hormones 186
radioimmunoassay 185
tissue receptor assay 187
Radiolabeled platelets 333
Radionuclide 10
source 10
cyclotrons in medicine 11
generator 14
nuclear reactor 10
Radionuclide cisternography 135
Radionuclide joint imaging 427
Radionuclide liver imaging 358
hepatic blood flow estimation 361
hepatic trapping index 362
imaging of liver with colloids 363
quantitative hepatic receptor
imaging 363
types of cells in liver 358
hepatic blood pool 361
hepatic stellate cells 359
hepatocytes 358
Kupffer cells 359
pit cells 305
Radionuclide lung imaging 315
equilibrium technique 316
equilibrium 316
single breath 316
washout 316
interpretation terminologies of
V/Q scan 320
labeled macro-aggregates 316
pulmonary embolism and infarct
role of radiology 321
radioactive aerosols 318
radioactive gases 315
Radionuclide therapy 462
antisense oligonucleotides 469
choice of radiolabel 464
concept molecular surgery 467
immuno-liposomes 469
malignant pheochromocytoma
nanobodies 469
NIS expression in other tissues
peptide receptor radionuclide
therapy 467
principles 462
ideal attributes of
radiopharmaceuticals 462
radioiodine therapy for thyroid
cancer 465
radioiodine therapy in
thyrotoxicosis 465
somatostatin receptor
radionuclide therapy 467
therapy of SSTR positive pediatric
tumors 467
Radionuclide venography 332
Radionuclides in hematology 383
blood volume determination 386
ferrokinetics 384
imaging of bone marrow 387
isotopic labels of cellular elements
of blood 383
RBC life span studies 386
splenic sequestration 385
studies for hypertension 386
Radiotracers 335
Relative renal function 280
Renal autoregulation 276
Renal nuclear medicine 276
Renal perfusion imaging 277
Resistin 237
Review of candidate genes 304
genes related to endothelial
function 304
adrenomedullin (ADM) gene
endothelial nitric oxide
synthase (eNOS) gene 304
endothelin receptors EDNRA
and EDNRB 305
insulin receptor substrate
(IRS) genes 306
phospholipase 305
prostacyclin synthase 305
selectin E 305
genes related to ion transport 309
hydroxysteroid
dehydrogenase 310
adducing gene 310
beta -2 adrenoreceptor gene
dopamine betahydroxylase
DBH 311
epithelial sodium channel 309
phenylethanolamine N
methyl transferase 311
sodium-lithium
cotransporters 309
aldosterone synthase gene
polymorphism 308
angiotensin II receptors 308
angiotensin-converting
enzyme (ECE) 307
angiotensinogen gene 307
bombesin-like receptors 309
bradykinin receptor B2 309
hypertension associated SA
mineralocorticoid receptor
(MCR) 308
natriuretic peptide 308
renin gene 306
RNA synthesis 74
Role of small animal PET and SPECT
in drug discovery 89
S
Schilling test 351
Sentinel node identification 477
Small animal PET in India 90
Solitary thyroid nodules 219
types 219
benign adenomas 219
carcinoma 219
colloid nodules 219
thyroid cysts 219
SPECT and PET in epilepsy 156
SPECT brain imaging for
cerebrovascular disease 152
Study of chromosomes 74
T
Tc-99 glucaric acid 268
Technetium chemistry 20
1-123 ANP imaging in vivo 29
clinical examples 26
cancer 26
neurology and psychiatry 26
evolution of the receptor concept
imaging steroid receptors 29
indium-113m
radiopharmaceuticals 22
iodine radiopharmaceuticals 22
labeling steroid receptor ligands
with Tc-99m 29
preparation of cyclotron
radiopharmaceuticals 22
regional perfusion and
metabolism 26
transporter and receptor imaging
Technetium generators 15
Technetium radiopharmaceuticals
Tests for gastrointestinal
malabsorption 349
breath test 349
urea breath test 349
Thrombus labeling agents 333
Thyroid cancer 222
anaplastic carcinoma 223
etiology 222
follicular carcinoma 222
lymphoma 223
medullary carcinoma 223
papillary carcinoma 222
Thyroid disease 207
apathetic hyperthyroidism 215
changes with aging 210
diagnosis of subclinical
hyperthyroidism 215
etiology 208
iodine deficiency and iodine
excess 208
iodine excess 208
factitious thyrotoxicosis 215
genetic factors 209
historical perspective 207
hypothyroidism 216
clinical features 217
investigations 211
imaging 211
laboratory tests 211
manifestations 212
hyperthyroidism 212
pathology 210
resistances to thyroid hormone 210
Thyroid nodules 218
Tritium labeling 72
chromosomal autoradiography 73
whole body autoradiography 72
Tuberculosis 223
U
Umbilical cord blood stem cells 271
Urinary dxylose test 351
Use of ARG 80
V
V/Q scan applications in non-
embolic lung disease 327
alveolar clearance 327
applications of alveolar clearance
studies 328
alveolitis 328
sarcoidosis 328
mucociliary clearance 327
Vesicoureteral reflux 293
W
Westermark's sign 322
Whiplash syndrome 156
X
Xenon for fatty liver 370
X-ray generators for CT 104
3D volume rendering (VR) 104
maximum intensity projection
(MIP) 105
multiplanar reformatting (MPR) 104
temporal resolution 105
×
Chapter Notes

Save Clear


What is Nuclear Medicine?CHAPTER 1

Nuclear Medicine is the application of nuclear energy (obtained in the form of radioactive materials) to the diagnosis and treatment of patients and to the study of human disease.
The impact of Nuclear Magnetic Resonance (NMR) and methodologies using stable isotopes and mass spectrometry (in the isotope dilution process), have led to a-new definition of Nuclear Medicine as “the medical speciality that utilizes the nuclear properties of radioactive and stable nuclides to make diagnostic evaluations of the anatomic and/or physiologic conditions of the body and to provide therapy with unsealed radioactive sources.”
For treatment, the radioactive material is administered in relatively large doses to exploit the lethal action of ionizing radiation upon living cells. For diagnosis and research the radioactive material is administered in doses which have no observable adverse biological effects. The tracer may be given orally, by inhalation, or most commonly, by intravenous injection. Its course through the body may be followed by radiation detectors placed externally over the body, or may be followed by taking samples of blood, urine, stools, expired air or tissue and analyzing them for radioactivity. Pictorial representation of distribution of radioactivity as a function of time is also obtainable, by scintigraphy.
By measuring the spatial distribution of the radiotracer at various points in time we can determine what is occurring within the body with respect to specific physiologic or biochemical processes, how fast and where such processes are occurring. The use of multiple tracers, each measuring a specific body function, adds the concept of functional resolution to spatial and temporal resolutions. These three concepts are fundamental to Nuclear Medicine.
Radio tracers are used in in vitro procedures like saturation analysis and neutron activation analysis of material obtained from patients. Since no radioactivity is administered to the patient in these procedures, their use can be extended to pregnant women and children as well, in whom one is reluctant to administer radioactive material unless it is absolutely essential.
 
TRACER PRINCIPLE
The most fundamental principle of Nuclear Medicine is the tracer principle invented by George Hevesy for which he was awarded the Nobel Prize in 1944. In the early 1920's Hevesy and his Coworkers used the then available naturally occurring radioisotopes of elements (thorium, bismuth lead, etc.) and studied their distribution in plants and animals. When artificially produced radioisotopes became available in the early 1930's, Hevesy again was the first to study the distribution of radioactive phosphorus in animals. His study strongly supported the concept of “dynamic equilibrium”: the formation of bone is a dynamic process; the bone is continuously taking up phosphorus atoms which are partly or wholly lost and again replaced by other phosphorus atoms. The concept of dynamic equilibrium was further expanded by Schoenheimer with the use of stable isotope of hydrogen-deuterium. The tracer principle and the dynamic state of body constituents occupy the central core of nuclear medicine.
 
MOLECULAR BIOLOGY AND NUCLEAR MEDICINE
The union of biology with physics and chemistry was the outstanding development of 20th Century Science. Physical and chemical approaches to problems in biology became increasingly productive giving rise to 2the new concepts of molecular biology and molecular medicine. The confluence of several powerful methods of observation—chemical analysis, electron microscopy, X-ray crystallography, electron spin resonance (ESR) nuclear magnetic resonance spectroscopy eventually led to the determination of the precise double helix architecture of DNA, the three dimensional configuration of protein molecules and the amino acid sequences of their constituent polypeptide chains and the precise characterization of most biologically active molecules. The synthesis of complex lipids and carbohydrates, the function of cell membranes and other cellular organelles and the accumulation and partitioning of inorganic ions occur as a secondary consequence of the action of specific proteins. Many of those proteins are enzymes that catalyze the biochemical conversion of one molecule into another. Some are structural proteins such as collagen and elastin, still others are regulatory proteins that dictate how much of each enzyme and each structural protein is made, when and where.
The human body is made up of trillions of cells which are constantly communicating with each other through recognition molecules. Molecular recognition is the fundamental feature of all biological processes encompassing ligand-receptor, substrate enzyme and antigen-antibody reactions. Nuclear medicine is uniquely placed to study biological events at the molecular level. As Dr Henry Wagner has been emphasizing for over three decades, the orientation of nuclear medicine is biochemical and not anatomical. Molecular nuclear medicine offers the opportunity of studying physiology and biochemistry at the molecular level, in the living human body including the brain. Hence nuclear medicine is closest to the body of general medicine than any other speciality in medicine. Now that the entire human Genome has become available for study, molecular nuclear medicine will enable us to connect genotype to phenotype via chemotype (Henry Wagner 1995).
“Molecular Nuclear Medicine can be the basis of both diagnosis and therapy. More and more, disease will be viewed as biochemical manifestations of biological processes. We may be able to diagnose some diseases biochemically before symptoms appear, with the potential to arrest or prevent the disease”. This statement of Dr Henry Wagner is best illustrated in the chapter 14 in this book which deals with the causation, prevention and reversal of vascular endothelial dysfunction, which along with insulin resistance causes the metabolic syndrome—visceral obesity, hypertension, Type 2 Diabetes mellitus and atherosclerosis. N-13 ammonia PET has shown diminished coronary flow reserve as an indicator of endothelial dysfunction in patients with angiographically and IVUS- normal coronary arteries. Endothelial dysfunction begins early in life, long before structural changes of atherosclerosis are seen. Lifestyle modification through diet, exercise and stress control can prevent and reverse endothelial dysfunction as shown by improvement in coronary flow reserve by N-13 ammonia PET, or Rubidium PET.
Radiochemists have developed stereo-specific ligands with the proper change, shape and lipophilicity for transport across cell membranes or the blood brain barrier. Growth promoting and growth-suppressing factors produced under the direction of genetic coding by proto-oncogene, oncogenes and antioncogenes can now be examined as they interact with cell membrane or intracellular receptors an enzymes in cancer cells as well as normal cells.
Table 1.1 lists the 20 intracellular signaling pathways known today and (Fig. 1.1) provides an illustrative example of one such pathway.
Molecular imaging techniques offer the possibility of monitoring the location, magnitude and persistence of reporter gene expression in intact living animals or humans (Gambhir SS 2000).
 
Scope of Diagnostic Nuclear Medicine Procedures
The diagnostic applications of radionuclides can be described under two major headings (a) procedures in which radioactivity is administered to the patient (b) procedures in which no radioactivity is administered to the patient but samples obtained from the patient are analysed by techniques involving the use of radioactive isotopes.
The procedures in which radioisotopes are administered to the patients can be broadly described under four categories.
  1. Dilution studies
    • Volumes and spaces
    • Turnover rates
    • Loss of tracer from the body3
      Table 1.1   Cell signalling pathways
      Pathways
      Clinical interest
      1. AKT pathways PKB signaling pathways
      Cancer, diabetes, stroke
      2. Apoptosis – Caspase activation
      Cancer
      3. Inhibition of apoptosis –AKt activation
      Autoimmune disorders
      4. Death Receptor Signaling. Fasligand
      Immunology
      5. Mitochondrial control of apoptosis : BCl2
      Neurodegenerative disorders
      6. Mitogen –activated Protein Kinase (MAKP)
      Inflammation
      7. MAPK / ERK
      Cancer cell proliferation
      8. G protein coupled receptor signaling
      Immune response
      9. SAPK / JNK signaling cascade
      Stress. Inflammation
      10. P38 MAPK
      Immune response
      11. Cell cycle control G1/S checkpoint
      Cancer
      12. Cell cycle control G2/M DNA point check point
      Cancer
      13. Translation control EelF4E elF2 P70S6
      Protein synthesis
      14. Protein Acetylation
      Insulin resistance
      15. Insulin Receptor Signaling
      Metabolic syndrome
      16. Wnt/b Catenin signaling pathways
      Cell fate decisions
      17. β-cell Receptor Signaling pathways
      During development ubiquitination and proteasomal degradate
      18. NF-KB signaling pathways
      Immune response, cancer
      19. TG-β signaling pathways
      Regulation of cell growth
      Differentiation, development
      20. Jal/ Stat signaling: IL-6 receptor family
      Cytokine receptor system –
      Cell growth and differentiation
      zoom view
      Fig. 1.1: Cell signaling pathways
      4
    • Gastrointestinal blood loss
    • Gastrointestinal protein loss.
  2. Dynamic function studies
    • Uptake tests (Radioiodine in thyroid)
    • Absorption tests
    • Clearance tests (e.g. renal clearance)
    • Breath analysis of C-14 CO2 : Radiorespirometry
    • Blood flow to organs
    • Organ function
      • Cardiac function
      • Hepatic function
      • Renal function.
    • Pulmonary ventilation and perfusion
      • Cerebral perfusion and function.
  3. Organ imaging: Selective concentration of a gamma-emitting or positron radiopharmaceutical in the organ of interest. An image of the distribution (scintigraphy) provides information regarding the position, size, boundaries and relationships of the organ. For most organs, the radiopharmaceuticals localize in normal functioning tissues. Diseased sites consequently are detected as areas of decreased or absent function. Brain lesions, bone lesions, myocardial infarcts, functioning adenomas of thyroid and adrenals, and functioning thyroid metastases are notable exceptions in which the area of abnormality appears as a locus of increased activity.
  4. Autoradiography: The action of radiation on a photographic emulsion is used to locate radio-activity in the specimen. Information can thus be obtained about the distribution of radioactivity on electrophoretic strips and chromatograms, in tissue sections, in individual cells, in cell nuclei and even in individual chromosomes. This technique is used in small animals for basic and pre-clinical research and drug development.
 
Radioactive Tracer Tests in vitro
  • Neutron activation analysis
    • Sample material bombarded with thermal neutrons in a nuclear reactor or cyclotron
    • Induced radioactivity helps identification and quantification of a variety of trace elements by scintillation spectrometry.
  • Saturation analysis and derivative analysis
    • Competitive protein-binding assay
    • Radioimmunoassay, radioreceptor assay
    • Immunoradiometric assay.
 
In vitro Radiorespirometry
  1. Biochemical reactions in isolated tissues can be assessed by measuring C-14 CO2 liberated when the tissues are incubated with C-14 labelled substrates. The released HCO2 can be captured in a vial or trapped in a filter paper soaked with potassium or sodium hydroxide.
  2. The presence of live bacteria in blood, urine or sputum samples can be detected by incubating samples with C-14 glucose or other substrate added to the usual culture media. If C-14 CO2 is evolved subsequently the test is positive, for this will not occur under sterile circumstances. This technique is particularly useful for tubercle and lepra bacilli. Drug sensitivity tests can be done much more rapidly than by conventional methods.
 
The Structure of the Atom
An understanding of radioactivity and of the interaction of radiation with matter is possible only if we have some concept (albeit oversimplified) of the structure of the atom.
The atom consists of a small central nucleus, about 10−12 cm in radius, very dense and positively charged. Surrounding the nucleus is a spherical region that is mostly empty space, occupied by negatively charged electrons, moving about rapidly and held in the atom by the pull of the positive charge of the nucleus. The “atmosphere” of the electrons extends about 10−8 cm outward from the nucleus. An oversimplified picture of the atom shows its electrons arranged in concentric shells that are identified by quantum numbers, N = 1, 2, 3, 4, 5, 6 and 7 or by letters K, L, M, N, O, P and Q beginning with the innermost shell. It is more realistic to show a “probability cloud” whose density represents the probability of finding the electron at a given position in the atom (Fig. 1.2).
The chemical identity of an atom is determined by the number of orbital electrons which it possesses; ordinary chemical reactions between different atoms involve interactions only between electrons in their outermost electron shells (Fig. 1.3).
The nucleus is a mass of protons and neutrons held tightly packed together by cohesive forces.5
zoom view
Fig. 1.2: The probability cloud model is somewhat nearer to the true model of atom. The blurred image represents a time exposure of electron motion. The reader visualized atom as having spherical shape
zoom view
Fig. 1.3: The subshell arrangement and the sizes of atoms. Hydrogen and chlorine are given as examples. Open circles represent that occupy each subshell
The proton has a mass of approximately 1 unit on the scale of mass used in atomic and nuclear physics, and carries a positive electric charge equal in magnitude to that of the electron. The number of protons in the nucleus is symbolized by 2, called by two names, the proton number and the atomic number.
The neutron has a mass similar to that of the proton but carries no electrical charge (hence the name). The number of neutrons in the nucleus is symbolized by N the neutron number. The sum of neutrons and protons is called A, the mass number (A = N + Z).
For most but not all atoms, the number of protons and neutrons in the nucleus are nearly equal; the mass number is then approximately twice the atomic number.
The number of stable arrangements of protons and neutrons is rather limited, and any other configuration of those particles results in an unstable nucleus. Such nuclei will* tend to assume a more stable configuration losing mass and electrical charges and disposing of excess energy by the emission of radiation. This process is called radioactive decay or disintegration.
Minute amounts of radioisotopes C-14 and H-3 (tritium) occur naturally in the garth's biosphere; they are formed as a result of the interaction of cosmic radiation with the elements in the atmosphere. A few naturally occurring radioisotopes are weakly radioactive such as uranium and thorium but are continually decaying into the stronger radionuclide Radium-226.
A nuclide is a species of atom characterized by its atomic number (Z), mass number (A) and the nuclear energy state.
Isotopes are nuclides of an element, characterized by having the same atomic number (Z) and hence the same chemical properties, but different mass number (different number of neutrons).
Stable isotopes: Since the neutron carries no electrical charge, the addition of an extra neutron will result in an increase of 1 unit in the mass number, without altering the chemical identity. Most naturally occurring elements exist as mixtures of two or more forms which differ in the number of neutrons in their nuclei.
Radionuclides are nuclides which are radioactive, i.e. which undergo spontaneous disintegration or transformation with the emission of radiation.
Radioisotopes are isotopes which are radioactive.
Illustrative example: Carbon, the most important element in biology, exists in the following forms (Fig. 1.4).
  • C-11—six protons and five neutrons.
  • C-12—six protons and six neutrons.
  • C-13—six protons and seven neutrons.
  • C-14—six protons and eight neutrons.
Carbon-11 is a neutron-deficient radioisotope which emits positrons; hence it is useful in positron emission tomography (PET).
Carbon-14 is a neutron-excess radioisotope which decays with beta emissions. Although it is unsuitable for use in the living humans due to its prolonged half-life (5000 years) it has played a crucial role in tracer studies in biochemistry and intermediate metabolism, and is currently utilised in a procedure designated as in vivo radiorespirometry.6
zoom view
Fig. 1.4: Examples of isotopes (top row) isobars (center row), and isotones (botton row). Protons in the nuclei are represented by black circles. The subdivision of the L-shells is not shown in this figure
Carbon-13 is a stable isotope of the ubiquitous carbon-12 but heavier than C-12. With the application of mass spectrometry “heavy” isotopes have found important applications in biochemical tracer work.
Carbon-13 has yet another nuclear property shared by nuclei with an odd number of protons and even number of neutrons (and vice versa)—that is intrinsic angular momentum or spin, which can be utilized for NMR (nuclear magnetic resonance) spectrometry and NMR imaging.
 
Nuclear Magnetic Resonance
Intrinsic angular momentum or spin is one of the fundamental properties of matter, beginning at the level of elementary particles. If a number of these particles (protons, neutrons) are grouped together to form a nucleus, their respective spins will add (by vector) and the nucleus will have a net nuclear spin. As a general rule, those nuclei with an even number of protons and neutrons will have zero net spin. Those nuclei with an odd number of protons or neutrons will have a net nuclear spin. The nucleus of hydrogen consists of a single proton, with a single orbital electron. Like a spinning top which also wobbles around its vertical axis, the protons of hydrogen also spin and have a wobble called precession. They behave like very tiny bar magnets of a definite strength or magnetic moment. If they are placed i n a magnetic field, they will line up more or less parallel to that field and will precess around it. The rate or frequency of this precession is proportional to the magnetic field strength in which they are placed.
In nuclear resonance, one makes use of this precession to study the atomic nuclei and their surroundings by exposing them to RF (radio-frequency) electromagnetic energy of exactly the same frequency as their precession. At that frequency they absorb energy from the radiation—resonance absorption—and change their alignment relative to the applied magnetic field. It is possible to turn them to 90° or 180°. After the RF field is removed the absorbed energy is released by the nuclei at particular frequencies—the strength being proportional to the proton density. The nuclei eventually return to their original orientation. This process is known as relaxation. The variables T1 and T2 are called the spin-lattice and spin-spin relaxation times. T1 is a measure of the connection between the spin system and its molecular environment and T2 is a measure of the connection between the spins themselves. By the use of those parameters important microscopic information about the human body is obtainable.
Hydrogen nuclei (protons), because of their high abundance (10 percent) in the human body and the strong NMR signal they generate, have been the focus of NMR imaging. The majority of hydrogen is formed in water molecules, although a significant proportion is present in fats and proteins. For this reason most of the NMR signal is derived from tissue water.
Another important atom with magnetic properties is phosphorus-31. The concentration P-31 which offers insight into basic intracellular metabolic process is 7several orders of magnitude lower than that of hydrogen (protons).
Fluorine-19 has excellent NMR characteristics and this may be exploited through fluorinated Pharmaceuticals and with fluoro-carbon blood substitutes.
Several other interesting atoms have nuclei with magnetic properties—deuterium H2, carbon-13, nitrogen-14 and nitrogen-15, oxygen-1 7, sodium-29, sulphur-31, sulphur-33, chlorine-35 and potassium-39. Unpaired electrons may also be imaged using electron paramagnetic resonance (EPR).
H-1, C-13 and P-31 have been fully used in NMR spectroscopy C-13 NMR spectroscopy has been used to measure the concentration of intracellular metabolites non-invasively such as glucose and glycogen in muscles (Shulman 1990). Details of such studies will be found in Chapter 14 (insulin resistance syndrome/metabolic syndrome and chapter 7 (Small animal PET and SPECT for basic research and drug development).
 
Nature of Radiation Energy
When an unstable nuclide reorders its nuclear components towards stability, the rearrangement leads to release of energy. Radionuclides disintegrate by six distinctly different nuclear processes, as shown in Table 1.2. In each case the atom loses discrete amount of energy that must be carried off by one or more atomic particles or by quanta of photons without mass, each type of disintegration can be indicated by a decay scheme, which is a combination of graph and an energy level diagram, (See appendix II).
Table 1.2   Nuclear disintegration processes
Name
Symbol
Radiation
Change in nucleus
Alpha decay
α
α
−2
−4
Beta decay
β
B, v, (γβ)
+1
0
Positron decay
b+
e, v, (γa),(γb)
−1
0
Electron capture
e.c.
v, (γ, e A)
−1
0
Internal conversion
c.e
e (γ, e A), (γb)
0
0
Gamma ray decay
γ
γ
0
0
Symbols:
v
neutrino
γ eA
Characteristic X-rays and Auger electrons resulting from the filling of an electron vacancy.
Bremsstrhlung photons produced by electrons and positrons.
Annihilation photons produced by positrons.
An alpha particle is essentially a helium nucleus consisting of two protons and two neutrons. It has relatively large mass, and low velocity and small penetrating powers, indeed a few inches of air or a sheet of paper will stop most alpha particles. Their ionizing affect is therefore sharply local, and is effectively exploited for therapy. It also means that alpha particles are of no possible use when the aim is to detect their presence with detectors placed outside the body.
A beta particle, an electron, has a negative charge, 7000 times smaller mass but more velocity compared to alpha particles, with enough energy to penetrate upto several millimeters of water. With sufficiently sensitive equipment beta radiation can be detected at the surface of the tissue if not too much tissue intervenes, but its range of ionization is still local enough for absorption of undesirably high radiation doses.
Positron decay, emission of positively charged electrons (or anti-electrons) is one way in which stability is restored in a nucleus with excess of positive charge. The positron will very shortly collide with an electron, and the two oppositely charged particles will disappear as matter, being converted into energy. The energy output of this transmutation consists of two gamma rays of 511 Kev energy emerging in almost opposite directions. The ability of detectors to locate the precise point in space where the transmutation took place is an important feature of PET (positron-electron transmutation tomography or positron emission tomography).
Electron Capture: In a radionuclide with excess protons stability is achieved by the shift of an electron from an inner orbit into the nucleus, thereby transforming an excess proton into a neutron. Energy released from this transaction of electron capture, is a photon known as characteristic X-ray,
Metastable State and Internal Conversion: A nucleus in a metastable state is under constant bombardment of the K shell electrons, to which the nucleus may transfer all its energy of excitation. The electron will then break off as a conversion electron. Following internal conversion, the atom is left with a vacancy in orbital electrons which will be filled by an electron, from a higher energy level—in this cascade the last 8vacancy will be filled by a “free electron” picked up by the atom to complete its full complement of electrons. Each time one of these electron transactions takes place, the atom loses energy either (1) by generation of a photon, known as characteristic X-ray, or (2) by freeing additional electrons from the atom through the Auger process.
Isomeric transition: Two nuclei having the same values of Z and the same values of N, but different nuclear configurations (which occur when one is excited to a different energy level from the other), are called isomers. The excited state comes to ground state simply by rearrangement of the internal structure. Energy is lost in this isomeric transition in the form of a photon (gamma ray).
The gamma ray is characterized by no mass, a velocity equal to that of light, a wavelength generally considerably shorter than that of X-rays, and great penetrating power. Their ionizing capabilities, therefore, can be detected at considerable distance from their source, making them suitable, for diagnostic purposes, with little or negligible local damage to the tissues. The energy of gamma rays is measured in terms of thousand electron volts (KeV). Gamma rays with energy around 200 KeV are well suited for usa with existing instruments.
The ideal gamma-emitting nuclide should decay by isomeric transition or electron capture without internal conversion. Those nuclides which decay with beta emissions or significant internal conversion, and those with longer than a few hours of physical half life, are less desirable. For diagnostic purposes it is desirable to give as large a dose as safely permissible, of a gamma-nuclide of minimally appropriate longevity, with energy characteristics as high as currently available instruments can efficiently utilize.
 
Radioactive Decay
Nuclear decay is a random process: for any individual radioactive atom we cannot predict exactly when it will disintegrate. We can only express a probability that it will disintegrate in any given time interval. With a large number of identical radioactive atoms, we can say how many we expect to disintegrate in each second on an average. The number of disintegrations per second is a measure of the strength of radioactivity of sample of radionuclide. An activity of one disintegration per second is called a becquerel, Bq. In nuclear medicine we are usually dealing with activities of several million disintegrations per second, i.e. megabecquerels, (mBq). Traditional unit of radjoactivity, the curie was defined as the activity of one gramme of radium, which is equal to 3.7 × 1010 disintegrations per second. The submultiples of the curie are millicurie (mCi) and microcurie μCi).
zoom view
The activity A, of a radioactive source, measured in disintegrations per second, is equal to the number of radioactive atoms present, N, multiplied by the probability that any one of them will decay in one second. If we call this probability as lamda (λ), then
A = AN. The activity may also be defined at the rate at which N is decreasing. Thus—
The solution of this differential equation gives the activity at any time as
zoom view
Where A0 is the activity at time t = 0. This is known as exponential decay.
The rate of decay can also be specified by the half life (t½) as the time it takes for half of the given amount of radioactivity to decay, that is the time at A/A0 =. 54. It is related as follows:
zoom view
The activity will halve in each half-life irrespective of when measurements are started. For example technetium — 99m has a half-life of 6 hours. A source which has an activity of 8 mCi at 8 a.m. will have only half of this value (4 mCi) at 2 p.m., and by 8 p.m. it will be 2 mCi. After 2 days the activity will be only 51 uCi (1/256 of the original activity) but it will still halve during the next 6 hours.
The development of instruments, choices of radionuclides, and effective use of gamma rays and X-ray sources in nuclear medicine depend upon our understanding of the behavior of the three interactions – alpha decay, isobaric transitions (beta decay, positron decay, electron capture) and isomeric transitions (gamma rays, internal conversion).
 
Pediatric Nuclear Medicine
Forty percent of the Indian population belong to pediatric and adolescent age group, hence it is useful to know the application of nuclear medicine in infant and children, keeping in mind the dosimetric considerations (Table 1.3).9
Table 1.3   Pediatric nuclear medicine
1. Nephro-urology:
  • Antenatally detected hydronephrosis
  • Congenital ureteropevic junction anomaly
  • Vesicouretoral reflux and pyelonephitis
  • Posterior urethral valve,
  • Duplex kidney.
  • Multicystic dysplastic kidney.
2. Gastrointestinal tract:
  • GI bleed: Meckel's diverticulum
  • Gastroesophageal reflux.
  • Pulmonary aspiration.
  • GI protein loss.
  • Colonic transit: functional fecal retention-chronic constipation.
  • Appendicites
  • Inflammatory bowel disease.
3. Liver and gallbladder:
  • Biliary atresia Vs neonatal hepatitis.
  • Biliary obstruction and cholecystitis
  • Biliary leaks
4. Pancreas:
  • Infantile hyperinsulinesm
5. Neurology:
  • Epilepsy –(drug resistant)
  • TEL: Ictal and interictal SPECT and PET
  • Extra-temporal-focal cortical dysplasia.
  • Hypoxic ischemic encephalopathy
  • Traumatic brain injury
  • Brain tumors
6. Oncology:
  • Neuroblastoma, Wilm's tumors
  • Neuroendocrine tumors (NETs)
  • Multiple endocrine neoplasia
  • CNS tumors
  • Lymphoma, leukemia
7. Bones:
  • Legg-Perthes disease.
  • Osteogenesis inperfecta
  • Fractures, osteomyelitis, sickle cell bone infarcts
  • Battered child syndrome
  • Osteosarcoma; Ewing's sarcoma
8. Soft tissue:
  • Rhabdomyosarcoma
9. Thyroid:
  • Agenesis, dyshormonogenesis
  • Pediatric thyroid cancer
10. Cardiac:
  • Assessment of left to right shunts and right to left shunts.
BIBLIOGRAPHY
  1. Gambhir SS. Imaging gene expression: concepts and future outlooks. In Schiepers C (ed): Diagnostic Nuclear Medicine Springer Verlay  Berlin.  2000: 253–72.
  1. Henry Wagner. Molecular Nuclear Medicine: From genotype to phenotype via chemotype J Nucl Med 1995.
  1. Hevesy G Adventures in Radioisotope Research. The collected papers of Gene Pergamon Press  Hevesy Nx  1962.
  1. Hevesy G Radioelements as tracers in physics and chemistry Chem News 1913;108: 66.
  1. Hevesy G The absorption and translocation of lead by plants. A contribution to the application of the method of radioactive indicators in the investigation of the change of substance in plants. Bio Ch 1923; 17: 439–45.
  1. Krasak M. et al Intramyocellular lipid concentrations are correlated with insulin resistance in human – a H-1NMR spectroscopy study. Diabetologia 1999; 42: 113–16.
  1. Rothman DI, Shulman RG, Shulman GI P-31 NMR measurements of muscle G6P J Clin Invest 1992;89: 1069–75.
  1. Schoenheimer R, Clarke HT The dynamic state of body constituents Harvard Univ. Press.  Cambridge MA  1949
  1. Shulman GI et al Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin dependent diabetes mellitus by C-13 NMRS N Eng J Med. 1990;322: 223–28.